These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 15477198)

  • 1. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
    De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C
    Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
    Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
    Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
    Barton JC; Lafreniere SA; Leiendecker-Foster C; Li H; Acton RT; Press RD; Eckfeldt JH
    Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HFE mutations, iron deficiency and overload in 10,500 blood donors.
    Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
    Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
    Acton RT; Barton JC; Leiendecker-Foster C; Zaun C; McLaren CE; Eckfeldt JH
    Blood Cells Mol Dis; 2010 Apr; 44(4):252-6. PubMed ID: 20178892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
    Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
    Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.
    Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M
    Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFE gene mutations an Apulian population: allele frequencies.
    Pietrapertosa A; Vitucci A; Campanale D; Palma A; Renni R; Delios G; Tannoia N
    Eur J Epidemiol; 2003; 18(7):685-9. PubMed ID: 12952143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.
    Aranda N; Viteri FE; Montserrat C; Arija V
    Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population screening for hemochromatosis: a study in 5370 Spanish blood donors.
    Sánchez M; Villa M; Ingelmo M; Sanz C; Bruguera M; Ascaso C; Oliva R
    J Hepatol; 2003 Jun; 38(6):745-50. PubMed ID: 12763366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.
    Cukjati M; Vaupotic T; Rupreht R; Curin-Serbec V
    BMC Med Genet; 2007 Nov; 8():69. PubMed ID: 18036208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
    Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
    Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for iron overload in the Turkish population.
    Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
    Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of HFE mutations among Turkish blood donors according to transferrin saturation: genotype screening for hereditary hemochromatosis among voluntary blood donors in Turkey.
    Simsek H; Sumer H; Yilmaz E; Balaban YH; Ozcebe O; Hascelik G; Buyukask Y; Tatar G
    J Clin Gastroenterol; 2004 Sep; 38(8):671-5. PubMed ID: 15319650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy.
    Cassanelli S; Pignatti E; Montosi G; Garuti C; Mariano M; Campioli D; Carbonieri A; Baldini E; Pietrangelo A
    J Hepatol; 2001 Apr; 34(4):523-8. PubMed ID: 11394651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.